PNV.AX
PolyNovo Limited
ASXAUDEQUITY
Healthcare
DELAYED
Last price
1.07
▼ 0.04 (3.60%)
MARKET · —
Price
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1.09
Prev close
1.11
Day high
1.10
Day low
1.06
Volume
1.90M
Market cap
$739.20M
P/E (TTM)
107.00
52W range
0.81 – 1.67
Trailing performance
Returnvs SPY
1W
+10.88%
+12.2%
1M
+15.68%
+11.9%
3M
-15.75%
-18.8%
6M
+18.23%
+7.2%
YTD
-13.01%
-25.3%
1Y
-10.83%
-30.8%
3Y
-29.14%
-103.3%
5Y
-46.50%
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on PNV.AX open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
76.17M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Mar 12, 26 | Douglas (Robert) Director (Non-Executive) |
BUY | 151.00K | $71.00K | Direct |
| Feb 25, 26 | Hoare (Leon) Director (Non-Executive) |
BUY | 30.00K | $20.00K | Direct |
| Feb 24, 26 | Lumsden (Andrew Stuart) Director (Non-Executive) |
BUY | 100.00K | $64.45K | Direct |
| Sep 19, 25 | Williams (David John) Non Executive Chairman |
BUY | 55.00K | $58.00K | Direct |
| Sep 17, 25 | Elliot (Robyn) Director (Non-Executive) |
BUY | 20.00K | $21.28K | Direct |
| Sep 15, 25 | Williams (David John) Non Executive Chairman |
BUY | 50.03K | $50.02K | Direct |
| Sep 12, 25 | Williams (David John) Non Executive Chairman |
BUY | 61.34K | $57.15K | Direct |
| Sep 11, 25 | Hoare (Leon) Director (Non-Executive) |
BUY | 20.00K | $18.53K | Direct |
| Sep 11, 25 | Williams (David John) Non Executive Chairman |
BUY | 31.00K | $28.48K | Direct |
| Sep 10, 25 | Williams (David John) Non Executive Chairman |
BUY | 37.00K | $34.37K | Direct |
| Jun 30, 25 | Gielen (Jan) Chief Financial Officer |
— | 345.00K | — | Direct |
| Jan 10, 25 | Williams (David John) Non Executive Chairman |
SELL | 750 | $935 | Direct |
| Sep 30, 24 | Lumsden (Andrew Stuart) Director (Non-Executive) |
SELL | 50.00K | $90.50K | Direct |
| Sep 26, 24 | Hoare (Leon) Director (Non-Executive) |
SELL | 100.00K | $179.84K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
Douglas (Robert) |
Director (Non-Executive) | 151.00K | Purchase |
Elliot (Robyn) |
Director (Non-Executive) | 94.79K | Purchase |
Gielen (Jan) |
Chief Financial Officer | 300.00K | Other |
Hoare (Leon) |
Director (Non-Executive) | 1.13M | Purchase |
Lumsden (Andrew Stuart) |
Director (Non-Executive) | 200.00K | Purchase |
Rathie (Bruce) |
Director (Non-Executive) | 2.50M | Sale |
Williams (David John) |
Non Executive Chairman | 21.66M | Purchase |
Fundamentals
Market cap$739.20M
Enterprise value$728.13M
Revenue (TTM)$139.49M
Gross profit$121.95M
EBITDA$6.65M
Net income$9.88M
EPS (TTM)$0.01
Free cash flow$-6.94M
Total cash$29.26M
Total debt$18.19M
Book value / share$0.12
Shares outstanding690.84M
Float616.76M
Short % of float—
Dividend yield—
Beta (5Y)1.35
Valuation & profitability ratios
Trailing P/E107.00
Forward P/E49.17
PEG ratio1.53
Price / sales—
Price / book8.92
EV / revenue5.22
EV / EBITDA109.54
Gross margin87.43%
Operating margin3.00%
Profit margin7.08%
Return on equity12.46%
Return on assets2.27%
Debt / equity21.88
Current ratio3.04
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $127.24M | $103.19M | $65.24M | $41.44M | +23.3% |
| Operating revenue | $127.24M | $103.19M | $65.24M | $41.44M | +23.3% |
| Cost of revenue | $5.20M | $5.48M | $4.43M | $2.20M | -5.2% |
| Gross profit | $122.05M | $97.71M | $60.81M | $39.24M | +24.9% |
| Research & development | $8.46M | $10.93M | $7.43M | $5.75M | -22.6% |
| Selling, general & admin | $98.56M | $78.55M | $53.20M | $29.84M | +25.5% |
| Total operating expense | $117.56M | $96.55M | $66.99M | $39.49M | +21.8% |
| Operating income | $4.48M | $1.16M | -$6.19M | -$256.65K | +285.6% |
| Net interest income | -$395.00K | $814.00K | $155.46K | -$409.91K | -148.5% |
| Pre-tax income | $7.52M | $1.71M | -$4.93M | -$1.15M | +339.5% |
| Tax provision | -$5.70M | -$3.55M | -$8.56K | $41.61K | -60.4% |
| Net income | $13.21M | $5.26M | -$4.92M | -$1.19M | +151.2% |
| Net income to common | $13.21M | $5.26M | -$4.92M | -$1.19M | +151.2% |
| Basic EPS | 0.02 | 0.01 | -0.01 | -0.00 | +151.3% |
| Diluted EPS | 0.02 | 0.01 | -0.01 | -0.00 | +152.0% |
| EBIT | $7.75M | $1.85M | -$4.75M | -$835.56K | +318.7% |
| EBITDA | $10.45M | $4.05M | -$2.71M | $753.46K | +158.3% |
| Basic shares | 690.72M | 690.23M | 684.45M | 660.87M | +0.1% |
| Diluted shares | 699.15M | 701.47M | 684.45M | 660.87M | -0.3% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $33.53M | $45.91M | $46.85M | $6.10M | -27.0% |
| Cash & short-term investments | $33.59M | $45.96M | $46.90M | $6.15M | -26.9% |
| Accounts receivable | $22.72M | $19.06M | $12.37M | $5.53M | +19.2% |
| Inventory | $14.49M | $8.97M | $4.53M | $2.54M | +61.5% |
| Total current assets | $77.10M | $79.30M | $67.35M | $16.19M | -2.8% |
| Property, plant & equipment | $38.22M | $24.17M | $23.37M | $16.75M | +58.2% |
| Goodwill & intangibles | $661.00K | $909.00K | $1.16M | $1.40M | -27.3% |
| Total assets | $127.41M | $108.72M | $92.62M | $34.97M | +17.2% |
| Total current liabilities | $27.88M | $23.25M | $12.67M | $7.76M | +19.9% |
| Current debt | $1.50M | $1.89M | $1.40M | $1.33M | -20.8% |
| Long-term debt | $2.22M | $742.00K | $1.79M | $2.80M | +198.8% |
| Total debt | $17.14M | $15.38M | $16.04M | $10.99M | +11.4% |
| Total liabilities | $44.15M | $36.60M | $27.24M | $17.26M | +20.6% |
| Retained earnings | -$102.90M | -$116.12M | -$121.38M | -$116.45M | +11.4% |
| Shareholder equity | $83.26M | $72.12M | $65.38M | $17.72M | +15.4% |
| Working capital | $49.22M | $56.05M | $54.69M | $8.43M | -12.2% |
| Net tangible assets | $82.60M | $71.22M | $64.23M | $16.31M | +16.0% |
| Shares issued | 690.84M | 690.23M | 690.23M | 661.69M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Capital expenditure | -$13.93M | -$2.90M | -$1.53M | -$491.93K | -380.9% |
| Investing cash flow | -$13.22M | -$1.49M | -$848.77K | $5.86M | -787.0% |
| Financing cash flow | -$2.39M | -$3.17M | $48.06M | -$5.39M | +24.6% |
| Free cash flow | -$10.78M | $786.00K | -$8.14M | -$2.55M | -1,471.9% |
| End cash position | $33.53M | $45.91M | $46.85M | $6.10M | -27.0% |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
| Line item | 2025-06-30 | YoY |
|---|---|---|
| Cash & equivalents | $33.53M | |
| Cash & short-term investments | $33.59M | |
| Accounts receivable | $22.72M | |
| Inventory | $14.49M | |
| Total current assets | $77.10M | |
| Property, plant & equipment | $38.22M | |
| Goodwill & intangibles | $661.00K | |
| Total assets | $127.41M | |
| Total current liabilities | $27.88M | |
| Current debt | $1.50M | |
| Long-term debt | $2.22M | |
| Total debt | $17.14M | |
| Total liabilities | $44.15M | |
| Retained earnings | -$102.90M | |
| Shareholder equity | $83.26M | |
| Working capital | $49.22M | |
| Net tangible assets | $82.60M | |
| Shares issued | 690.84M |
No filings published for this symbol yet.
Newly listed companies often have nothing on file until their first annual report.
Newly listed companies often have nothing on file until their first annual report.
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $36.00M | — |
| Next quarter | — | — | $40.20M | — |
| Current year | 0.01 | 4 | $146.49M | +13.4% |
| Next year | 0.02 | 5 | $169.00M | +15.4% |
Analyst targets & ownership
Mean target$1.46
High target$2.65
Low target$0.95
Implied upside36.49%
Analyst count8
ConsensusBUY
Strong buy / Buy1 / 4
Hold3
Sell / Strong sell0 / 0
Held by insiders11.03%
Held by institutions38.10%
Institutions holding42
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1.00
+6.63% from price
SMA 20
0.93
+14.75% from price
SMA 50
0.96
+12.01% from price
SMA 100
1.00
+6.74% from price
SMA 200
1.04
+2.71% from price
EMA 12
1.00
+6.84% from price
EMA 26
0.97
+10.35% from price
EMA 50
0.97
+10.18% from price
RSI (14)
64.5
Neutral
MACD (12,26,9)
0.03
Hist 0.02
ATR (14)
0.05
4.74% of price
Realised vol 30D
54.5%
Annualised
Bollinger upper
1.10
20, 2σ
Bollinger lower
0.77
20, 2σ
50 / 200 cross
Death
0.96 vs 1.04
Trend bias
Above 200
+2.71%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.38
Less volatile than market
Correlation to SPY
0.09
Largely independent
Realised vol 30D
54.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-49.8%
Peak to trough
Max drawdown 5Y
-70.0%
Peak to trough
ATR 14
0.05
4.74% of price
Beta (reported)
1.35
5Y monthly, from filing
Dividends & splits
Forward rate—
Forward yield—
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split0.1429:1
Split dateMay 3, 2004
Headlines
Gundir Announces Gundir365(TM) Postage Promise, Locking In Direct Mail Postage Rates for a Full Year
ACCESS Newswire · 10m ago
Why Keysight Technologies Stock Sank This Week
Motley Fool · 16m ago
Sydney marathon unveils medal with wrong stadium
AFP · 19m ago
Atlassian (TEAM) Stock Looks Near Fair Value After Its 98% Run
Simply Wall St. · 23m ago
Is Vestas Wind Systems (CPSE:VWS) Fully Valued As Earnings Lifted Full Year Guidance?
Simply Wall St. · 23m ago
Clorox (CLX) Could Be 56% Below Fair Value As Valuation Views Split
Simply Wall St. · 23m ago
Red Cat Holdings (RCAT) Expands Blue Ops Integration, Is The Upside Already Priced In?
Simply Wall St. · 23m ago
Chiefs vs. Buccaneers highlights Preseason Week 2
NFL Highlights · 30m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.